UNSPSC 51342711: Interferon gamma-1b

This classification denotes an interferon, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 21K6M2I7AG. European Medicines Agency schedules Interferon alfa-n1 in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12076MIG. As of Q4 2014, INTERFERON GAMMA-1B remains the US FDA Preferred Term for this commodity. Interferon gamma-1b bears US NLM identifiers UMLS ID C1579322 and NCI Concept Code C100089. SMILES: NONE.

UNSPSC 51342711 Interferon gamma-1b is a Commodity code that nominally designates a specific pharmaceutical product, but the recent state and local opportunities posted under this code show little alignment with the code's intended scope. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride—antibiotics unrelated to interferon gamma-1b. Seminole County, Florida released an IFB for Naloxone and Safe Drug Deactivation Systems, similarly outside the code's stated product category. These opportunities suggest that state and local procurement offices are using this Commodity code for general pharmaceutical supply and emergency preparedness procurement rather than for the specific biologic agent the code nominally represents, or that the tagging reflects administrative convenience in shared procurement systems rather than precise product matching.

The mismatch between code designation and actual procurement makes this code a low-priority track for vendors specializing in interferon gamma-1b or related biologics. The Illinois Department of Public Health and Seminole County are the visible issuers in the recent block, but their contracts cover commodity pharmaceuticals and emergency supplies. If your firm supplies interferon gamma-1b to state or local health agencies, verify whether these jurisdictions have separate solicitations tagged to this code or whether they source the product through state health department standing agreements, cooperative purchasing consortia, or federal supply schedules rather than open state and local competitive bidding. The code itself shows no recent authentic activity aligned with its nominal scope.